Very late diagnosis of pituitary stalk interruption syndrome in a patient with dengue with warning signs

Authors

DOI:

https://doi.org/10.24265/horizmed.2024.v24n3.16

Keywords:

Hypopituitarism, Pituitary stalk, Hypogonadism

Abstract

Pituitary stalk interruption syndrome (PSIS) is a congenital genetic disorder that causes hypopituitarism, which is characterized by hypoplasia of the adenohypophysis, ectopic neurohypophysis and pituitary stalk interruption. The clinical manifestations are related to varying degrees of pituitary hormone deficiency (panhypopituitarism). The diagnosis is usually made late or goes unnoticed because it depends on the clinical manifestations presented, a fact that is associated with high morbidity and mortality in patients. We present the case of a 19-year-old female patient with a pathological history of nystagmus, toxoplasmosis, stunted growth and delayed pubertal development. She was admitted to the hospital emergency room because she presented with fever, dyspnea, polyarthralgia, headache, vomiting and oral intolerance. During hospitalization, sustained hypoglycemia refractory to the administration of dextrose was evidenced. Hence, laboratory tests were performed, revealing varying degrees of pituitary hormone deficiencies, with notable deficits in growth hormone, thyroid hormone and gonadotropic hormones, as well as hypocortisolism due to a deficiency in adrenocorticotropic hormone. Consequently, she was diagnosed with dengue with warning signs and panhypopituitarism. She responded well to the established treatment, showed good progress and was discharged with hormone replacement therapy. Early and timely diagnosis of PSIS prevents issues related mainly to metabolism, growth and development. Therefore, an adequate hormonal profile and imaging study of the pituitary gland is the key to diagnosis and treatment. In addition, timely recognition and treatment improve the prognosis, quality of life and life expectancy of patients.

Downloads

Download data is not yet available.

References

Mendoza-Borja K, Ramos-Noriega S, Aguilar-Britto E, Guerrero-Roa W, García-Bermejo R. Síndrome de interrupción del tallo hipofisario: reporte de caso y revisión de la literatura de una paciente con diagnóstico tardío. Rev Pediatría [Internet]. 2023;56(4).

Díaz A, Albán León L. Síndrome de interrupción del tallo hipofisario: reporte de un caso. Metro Ciencia [Internet]. 2022;30(1):11-3.

Martell González MR, Cuevas Bailón MA. Diagnóstico radiológico del síndrome de interrupción del tallo hipofisiario. Neurohipófisis ectópica. Rev Fac Med [Internet]. 2021;64(1):32-6.

Müller A, Romero F, Arzamendia S, Ferreira D, Neves De Souza C, Castellano B, et al. Interrupción del tallo hipofisario como causa poco frecuente de amenorrea primaria. Rev Científica Cienc Salud [Internet]. 2021;3(2):112-5.

A Chrzanowska J, Zubkiewicz-Kucharska A, Seifert M, Całkosiński A, Noczyńska A. Clinical evaluation of 31 children with pituitary insufficiency in the course of the pituitary stalk interruption syndrome. The unexpected growth without growth hormone in 2 children. Pediatr Endocrinol Diabetes Metab [Internet]. 2021;27(4):272-82.

Wang Q, Meng X, Sun Y, Liu F, Xu C, Qiao Y, et al. Hypoglycemia and jaundice in newborns with pituitary stalk interruption syndrome. Medicine (Baltimore) [Internet]. 2021;100(19):e25843.

Sridhar S, Raja BR, Priyanka R, Natarajan S, Soundararajan S, Natarajan V, et al. Clinico-radiological correlation of pituitary stalk interruption syndrome in children with growth hormone deficiency. Pituitary [Internet]. 2023;26(5):622-8.

Zhang W, Qian F, Lu G, Wu Y, Li R, Xia L, et al. Pituitary stalk interruption syndrome: A rare case report and literature review. Medicine (Baltimore) [Internet]. 2020;99(50):e23266.

Wu Ze-Yu, Li Yi-Ling, Chang B. Pituitary stalk interruption syndrome and liver changes: from clinical features to mechanisms. World J Gastroenterol [Internet]. 2020;26(44):6909-22.

Terray A, Baussart B, Zins M, Goldberg M, Kab S, Cazabat L, et al. Gonadotropic status in adult women with pituitary stalk interruption syndrome. Eur J Endocrinol [Internet]. 2024;190(6):501-8.

Brauner R, Bignon-Topalovic J, Bashamboo A, McElreavey K. Pituitary stalk interruption syndrome is characterized by genetic heterogeneity. PLoS One [Internet]. 2020;15(12):e0242358.

Fatima T, Hussain Chandio S, Muzaffar K, Mumtaz H, Jahan N. Pituitary stalk interruption syndrome. Cureus [Internet]. 2020;12(9):e10518.

Eren E, Ongen YD, Ozgur T, Ozpar R, Demirbas O, Yazici Z, et al. Normal or elevated prolactin is a good indicator to show pituitary stalk interruption syndrome in patients with multiple pituitary hormone deficiency. J Pediatr Endocrinol Metab [Internet]. 2022;35(11):1394-400.

Voutetakis A. Pituitary stalk interruption syndrome. Handb Clin Neurol [Internet]. 2021;181:9-27.

Zhang Y, Zhao X, Chen M. Clinical analysis of 10 cases of pituitary stalk interruption syndrome and literature review. Neuro Endocrinol Lett [Internet]. 2021;42(3):150-6.

Published

2024-09-17

How to Cite

1.
Sernaque Mechato RA, Torres Hu WJ, Blaz Ladera JA, López Durand MV, Navarro Suarez EI, Trejo Rodriguez RH, Flores-Araoz DR. Very late diagnosis of pituitary stalk interruption syndrome in a patient with dengue with warning signs. Horiz Med [Internet]. 2024Sep.17 [cited 2025May2];24(3):e2868. Available from: https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/2868

Issue

Section

Case report